First Trust Nasdaq Pharmaceuticals ETF (FTXH) |
| 35.0236 -0.142 (-0.4%) 05-29 16:00 |
| Open: | 35.15 |
| High: | 35.15 |
| Low: | 34.92 |
| Volume: | 2,137 |
| Market Cap: | 35(M) |
| PE Ratio: | 23.72 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 41.14 |
| Resistance 1: | 35.22 |
| Pivot price: | 34.40 |
| Support 1: | 33.93 |
| Support 2: | 33.13 |
| 52w High: | 35.611 |
| 52w Low: | 25.33 |
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 14 Nov 2025
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - Yahoo Finance
Thu, 16 Oct 2025
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
Fri, 26 Sep 2025
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
Thu, 17 Jul 2025
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - Yahoo Finance
Thu, 21 Sep 2023
The 5 Best Pharmaceutical ETFs of 2023 - ETF.com
Fri, 21 Jul 2023
5 ETFs to Buy on JNJ's Q2 Earnings Strength - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
